-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Blueprint Medicines Corp quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q3 2024.
- Blueprint Medicines Corp Costs and Expenses for the quarter ending September 30, 2024 was $177M, a 4.52% decline year-over-year.
- Blueprint Medicines Corp Costs and Expenses for the twelve months ending September 30, 2024 was $710M, a 4.93% decline year-over-year.
- Blueprint Medicines Corp annual Costs and Expenses for 2023 was $736M, a 0.8% decline from 2022.
- Blueprint Medicines Corp annual Costs and Expenses for 2022 was $742M, a 9.79% decline from 2021.
- Blueprint Medicines Corp annual Costs and Expenses for 2021 was $822M, a 69.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)